Literature DB >> 16222702

Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation.

Mimmo Turano1, Giuliana Napolitano, Cyprien Dulac, Barbara Majello, Olivier Bensaude, Luigi Lania.   

Abstract

The HEXIM1 protein, in association with 7SK snRNA, binds and inhibits the kinase activity of P-TEFb (CDK9/cyclin T). P-TEFb activity is crucial for efficient transcription elongation of viral and cellular genes. HEXIM1 was originally isolated as a protein up-regulated by hexamethylene bisacetamide (HMBA), a prototypical inducer of differentiation. To determine the causative role of HEXIM1 during cell differentiation we analyzed the biochemical and functional consequences of HEXIM1 protein levels in several in vitro differentiation systems. We found that HEXIM1 mRNA and protein levels are up-regulated during differentiation of murine erythroleukemia cells upon treatment with HMBA or DMSO. Stimulation of HEXIM1 is not restricted to hematopoietic cells, as induction of phenotypic differentiation of neuroblastoma cells by retinoic acid results in up-regulation of HEXIM1. Moreover, ectopic expression of HEXIM1 causes growth inhibition and promotes neuronal differentiation. These findings highlight a crucial role of HEXIM1 protein during cell differentiation. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16222702     DOI: 10.1002/jcp.20502

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

1.  HMBA is a putative HSP70 activator stimulating HEXIM1 expression that is down-regulated by estrogen.

Authors:  Rati Lama; Chunfang Gan; Nethrie Idippily; Viharika Bobba; David Danielpour; Monica Montano; Bin Su
Journal:  J Steroid Biochem Mol Biol       Date:  2017-02-14       Impact factor: 4.292

Review 2.  CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.

Authors:  Sungyoo Cho; Sebastian Schroeder; Melanie Ott
Journal:  Cell Cycle       Date:  2010-05-29       Impact factor: 4.534

3.  Lead optimization of HMBA to develop potent HEXIM1 inducers.

Authors:  Bo Zhong; Rati Lama; Wannarasmi Ketchart; Monica M Montano; Bin Su
Journal:  Bioorg Med Chem Lett       Date:  2014-01-17       Impact factor: 2.823

4.  Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism.

Authors:  Wannarasmi Ketchart; I-Ju Yeh; Haoyan Zhou; Praveena S Thiagarajan; Justin Lathia; Ofer Reizes; Agata Exner; Bin Su; Monica M Montano
Journal:  Cancer Lett       Date:  2016-05-26       Impact factor: 8.679

Review 5.  Retinoids regulate stem cell differentiation.

Authors:  Lorraine J Gudas; John A Wagner
Journal:  J Cell Physiol       Date:  2011-02       Impact factor: 6.384

6.  Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation.

Authors:  Nanhai He; Andrea C Pezda; Qiang Zhou
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

Review 7.  The Yin and Yang of P-TEFb regulation: implications for human immunodeficiency virus gene expression and global control of cell growth and differentiation.

Authors:  Qiang Zhou; Jasper H N Yik
Journal:  Microbiol Mol Biol Rev       Date:  2006-09       Impact factor: 11.056

8.  Cross-talk of GATA-1 and P-TEFb in megakaryocyte differentiation.

Authors:  Kamaleldin E Elagib; Ivailo S Mihaylov; Lorrie L Delehanty; Grant C Bullock; Kevin D Ouma; Jill F Caronia; Sara L Gonias; Adam N Goldfarb
Journal:  Blood       Date:  2008-09-09       Impact factor: 22.113

Review 9.  Megakaryocytic programming by a transcriptional regulatory loop: A circle connecting RUNX1, GATA-1, and P-TEFb.

Authors:  Adam N Goldfarb
Journal:  J Cell Biochem       Date:  2009-06-01       Impact factor: 4.429

10.  A La-related protein modulates 7SK snRNP integrity to suppress P-TEFb-dependent transcriptional elongation and tumorigenesis.

Authors:  Nanhai He; Nadine S Jahchan; Eunmee Hong; Qiang Li; Mark A Bayfield; Richard J Maraia; Kunxin Luo; Qiang Zhou
Journal:  Mol Cell       Date:  2008-01-31       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.